Novopharm Ltd. v. Novartis Pharmaceuticals Canada Inc.

The court concluded Dawson J. did not err in her assessment of the exercise of discretion by Prothonotary Giles and therefore the appeal was dismissed with costs.

Citation: 2002 FCA 192
Parties: Appellant (defendant): Novopharm Limited; Respondent (plaintiff): Novartis Pharmaceuticals Canada Inc.
Court: Federal Court of Appeal
Jurisdiction: Canada
Judgment Date: 13 May 2002
Procedural Posture: Appeal / Judgment of the Federal Court of Appeal
Outcome: Appeal dismissed with costs.
Legal Topics: Exercise of Discretion, Costs, Procedural Order
Source Language: English

Civil Procedure Appeal Exercise of Discretion Costs Procedural Order

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Legal principles 2 Party arguments 2

Parties

Novopharm Limited

Appellant (defendant)

Novartis Pharmaceuticals Canada Inc.

Respondent (plaintiff)

Procedural Posture

Appeal / Judgment of the Federal Court of Appeal

Legal Issues

1 Whether Dawson J. erred in her assessment of the exercise of discretion by Prothonotary Giles
2 Whether the appellate court should overturn the lower court's exercise of discretion
3 Whether the appeal should be allowed or dismissed

Ratio Decidendi

The court concluded Dawson J. did not err in her assessment of the exercise of discretion by Prothonotary Giles and therefore the appeal was dismissed with costs.

Court Disposition

Appeal dismissed with costs.

Orders

Appeal dismissed with costs.